Intelligent Bio Solutions Seeks FDA Clearance For Fingerprint-Based Drug Screening System

Intelligent Bio Solutions submitted a 510(k) premarket notification to the FDA seeking clearance for its Intelligent Fingerprinting Drug Screening System to detect the opiate codeine. The filing could expand the system's testing capabilities if cleared, but the outcome and timing of FDA review remain uncertain.